The FDA has granted Janssen Pharmaceuticals approval for its type 2 diabetes drug Invokana. The drug, a sodium-glucose co-transporter 2 inhibitor, was the first of its class to gain federal approval.
Janssen gets FDA nod for type 2 diabetes drug
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||